|

Role of the Immune System in Preventing Laryngeal Cancer

RECRUITINGSponsored by European Institute of Oncology
Actively Recruiting
SponsorEuropean Institute of Oncology
Started2025-11-19
Est. completion2026-12-31
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07508319

Summary

Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Histopathological diagnosis of laryngeal dysplasia.
* Age \>18 years and informed consent.

Exclusion Criteria:

* Prior surgical, radiotherapeutic, or oncologic treatments for head and neck regions.
* Congenital or acquired immunodeficiency disorders.
* Synchronous malignancies.
* Immunosuppressive therapy.
* Age \<18 years or absence of research consent.

Conditions2

CancerHead Neck Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.